Factor works with strategic partners to develop and advance products based on our technologies to the clinic. Factor’s technologies have the potential to contribute to new therapeutic products, many of which will require testing in clinical trials. As a result, Factor collaborates with companies that have extensive experience in all stages of the therapeutic product development pipeline.

Pictured from right to left: Matt Angel, Ph.D., Co-Founder, Chairman, and CEO of Factor Bioscience Inc.; Gregory Fiore, M.D., Co-Founder and CEO of Exacis Biotherapeutics Inc.; Christopher Rohde, Ph.D., Co-Founder and Chief Technology Officer of Factor Bioscience Inc.